Johns Hopkins University preparing for ‘devastating’ cuts
Johns Hopkins University in Baltimore said it’s preparing for what it believes will be “devastating federal cuts” that could impact…
1033: Doxycycline Might Not Be As Good As We Thought…
Show notes at pharmacyjoe.com/episode1033. In this episode, I’ll discuss outcomes with doxycycline vs azithromycin for community-acquired pneumonia. The post 1033: Doxycycline…
1032: Five ICU Signals That Should Make Your Pharmacy Spidey-Sense Tingle
Show notes at pharmacyjoe.com/episode1032. In this episode, I’ll discuss five circumstances that should make an ICU pharmacist stop what they are…
1031: How Long Does it Take for IM Medications to Work in Acute Agitation?
Show notes at pharmacyjoe.com/episode1031. In this episode, I’ll discuss expectations for the onset of action of IM medications used for acute…
1030: Adding dexmedetomidine to lidocaine for topical application to prevent cough during extubation
Show notes at pharmacyjoe.com/episode1030. In this episode, I’ll discuss adding dexmedetomidine to lidocaine for topical application to prevent cough during…
1029: A Systematic Review of the Ketorolac Dose Ceiling for ED Analgesia
Show notes at pharmacyjoe.com/episode1029. In this episode, I’ll discuss a systematic review of the ketorolac dose ceiling for ED analgesia.…
1028: Three ways to tell the difference between serotonin syndrome and neuroleptic malignant syndrome
Show notes at pharmacyjoe.com/episode1028. In this episode, I’ll discuss three ways to tell the difference between serotonin syndrome and neuroleptic…
1027: Probiotics in the ICU – How Bad Can It Get?
Show notes at pharmacyjoe.com/episode1027. In this episode, I’ll discuss probiotic-associated central venous catheter bloodstream infections in the ICU. The post…
1026: Is the Low-Dose Ketamine In the Room With Us Right Now?
Show notes at pharmacyjoe.com/episode1026. In this episode, I’ll discuss hallucinations from low-dose ketamine use in the ICU. The post 1026:…
FDA 101: Product Recalls
Recalls are typically voluntary actions taken by a company to remove or correct products on the market that violate U.S.…